Literature DB >> 2623217

Pulmonary abnormalities in Crohn's disease.

J B Neilly1, A N Main, C McSharry, J Murray, R I Russell, F Moran.   

Abstract

Abnormalities of pulmonary function in Crohn's disease have been described, although the results are conflicting and anecdotal accounts of lung involvement are few. In this study we assessed the prevalence of lung function abnormalities in Crohn's disease, and the relative contributions of age, sex, smoking and past medical history, and Crohn's disease activity to the pulmonary abnormalities found. Twenty-nine patients with Crohn's disease and 29 age-, sex- and smoking-matched volunteer controls underwent detailed respiratory assessment. Airways obstruction due to chronic bronchitis and asthma was present in 13 patients with Crohn's disease, but was not more prevalent than in the control group. FEV1 was similar in both Crohn's disease and control subjects (84.2 +/- 21.2% predicted, mean +/- SD; 93.7 +/- 16.3%, respectively: n.s.). The vital capacity was significantly lower in the Crohn's disease patients than in controls (86.7 +/- 16.6%; 95.9 +/- 12.7%; P less than 0.01), but this may have been influenced by the higher prevalence of past or intercurrent medical illnesses affecting the chest in Crohn's disease patients. No patient had evidence of fibrosing alveolitis or bronchiectasis. The haemoglobin corrected transfer factor was significantly lower in the Crohn's disease patients than in controls (100.4 +/- 17.4%; 113.2 +/- 25.1: P less than 0.05) but the diffusing coefficient was not significantly different. There was a significant correlation (r = 0.44, P less than 0.05) between the residual volume and the Crohn's disease activity index but otherwise no close relationship was observed between Crohn's disease activity, extent or duration and the indices of lung function. These findings suggest that the lungs are relatively unaffected by Crohn's disease.

Entities:  

Mesh:

Year:  1989        PMID: 2623217     DOI: 10.1016/s0954-6111(89)80132-5

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  9 in total

Review 1.  Patterns of airway involvement in inflammatory bowel diseases.

Authors:  Ilias Papanikolaou; Konstantinos Kagouridis; Spyros A Papiris
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 2.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Xiao-Qing Ji; Li-Xia Wang; De-Gan Lu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 3.  [Bronchopulmonary manifestations of gastroenterologic and hepatic diseases].

Authors:  A Tromm; G H Micklefield; D Hüppe
Journal:  Med Klin (Munich)       Date:  1997-12-15

Review 4.  Pulmonary manifestations of Crohn's disease.

Authors:  De-Gan Lu; Xiao-Qing Ji; Xun Liu; Hong-Jia Li; Cai-Qing Zhang
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 5.  Pulmonary involvement and allergic disorders in inflammatory bowel disease.

Authors:  Nikolaos E Tzanakis; Ioanna G Tsiligianni; Nikolaos M Siafakas
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

6.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Sebastian Majewski; Wojciech Piotrowski
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

7.  Alterations of pulmonary function in patients with inflammatory bowel diseases.

Authors:  Xiao-Qing Ji; Yan-Bo Ji; Shan-Xin Wang; Cai-Qing Zhang; De-Gan Lu
Journal:  Ann Thorac Med       Date:  2016 Oct-Dec       Impact factor: 2.219

8.  Co-occurrence of Asthma and the Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis.

Authors:  M Ellen Kuenzig; Kirles Bishay; Richard Leigh; Gilaad G Kaplan; Eric I Benchimol
Journal:  Clin Transl Gastroenterol       Date:  2018-09-24       Impact factor: 4.488

9.  Subclinical Pulmonary Involvement in Active IBD Responds to Biologic Therapy.

Authors:  M Ellrichmann; J Bethge; J Boesenkoetter; C Conrad; R Noth; T Bahmer; S Nikolaus; K Aden; S Zeissig; S Schreiber
Journal:  J Crohns Colitis       Date:  2021-08-02       Impact factor: 9.071

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.